← Back

$ Value

$0

Shares

1,355

Price

$0

Filed

Nov 24

Insider

Name

Stanton Marshall S.

Title

SVP, Clinical & MD Affair

CIK

0001849615

Roles

Officer

Transaction Details

Transaction Date

2025-11-20

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

27,075

Footnotes

Reflects weighted average price. Range of prices were between $43.92 to $44.49. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. | Reflects weighted average price. Range of prices were between $44.26 to $44.44. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. | Reflects weighted average price. Range of prices were between $44.26 to $44.35. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023. | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

Filing Info

Accession No.

0001628280-25-053702

Form Type

4

Issuer CIK

0000784199

Stanton Marshall S.'s History

Date Ticker Type Value
2026-03-03 AORT $81K
2026-03-02 AORT $58K
2026-03-02 AORT A $0
2026-02-24 AORT $45K
2026-02-23 AORT $91K
2025-11-21 AORT M $374K
2025-11-21 AORT $655K
2025-11-21 AORT $259K
2025-11-21 AORT M $299K
2025-11-21 AORT $840K

Other Insiders at AORT (90d)

Insider Bought Sold Last
Horton Amy
VP, Chief Accounting Officer
$153K 2026-03-03
Mackin James P
President & CEO
$2.5M 2026-03-03
Berry Lance A
EVP, COO, CFO & Treasurer
$783K 2026-03-03
Holloway Jean F
SVP, General Counsel
$744K 2026-03-04
Davis John E
Chief Commercial Officer
$494K 2026-03-03
Stanton Marshall S.
SVP, Clinical & MD Affair
$275K 2026-03-03